The FDA is proposing a regulation that would allow products containing N-acetyl-L-cysteine (NAC) to be lawfully marketed as dietary supplements. This action would permit the addition of NAC to dietary supplements without violating the FD&C Act. The proposal aims to clarify the status of NAC in dietary supplements.
Who it affects
This proposal affects businesses that market or wish to market products containing NAC as dietary supplements.
What to do
Read the official document to confirm what applies to you.
Summary generated automatically from the abstract or description and not reviewed by a person. It can be wrong or incomplete. Rely on the official document.